US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HORIZON KINETICS MEDICAL ETF

34.96

-0.1032-0.29%

Post-market: 35.000.0428+0.12%16:10 EDT

Volume:2K

Turnover:66.28K

Market Cap:16.43M

PE:- -

High:35.10

Open:35.10

Low:34.96

Close:35.06

52wk High:37.90

52wk Low:28.87

Shares:469.95K

Float Shares:469.95K

Volume Ratio:0.73

T/O Rate:0.40%

Dividend:0.41

Dividend Rate:1.17%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Brain-Computer Interface Startups Must Walk the Line Between Vast Potential and Near-Term Medical Reality, Says Formatia Founder

Top Johnson & Johnson Executive Makes Major Stock Move

Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal

Stocks to Watch: Ionis Pharmaceuticals, Novartis, Corvex

Novartis Pelacarsen Fails Phase III Cardiovascular Outcomes Trial

MT Newswires Live

Novartis announces Phase 3 pelacarsen study did not meet primary endpoint

Estee Lauder Cos. Cl a Stock Outperforms Competitors on Strong Trading Day

Novartis Says Pelacarsen Heart Disease Drug Missed Primary Endpoint

AbbVie Inc. Stock Underperforms Friday When Compared to Competitors

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Mizuho survey shows no consensus into Alkermes ADHD data

Lilly Targets Type 1 Diabetes With New Tirzepatide Study: What Investors Should Watch

Novartis AG Falls Friday, Underperforms Market

Drugmakers Halt Autoimmune Trials After Deaths, Life-Threatening Side Effects

Analysts Are Bullish on Top Healthcare Stocks: Annovis Bio (ANVS), AbbVie (ABBV)

Wuhan Dazhong Dental Proposes Wang Hong as Executive Director to Replace Guo Jiaping

J&J EVP, Worldwide Chair MedTech Timothy Schmid Disposes of 33,597 Common Shares Worth $9.23 Million

Traditional Chinese Medicine Firm Secures Regulatory Approval for New Depression Treatment

Scotiabank Remains a Buy on AbbVie (ABBV)

Guizhou-Based Firm Earns National Recognition for Veterans Support Efforts

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/MEDX/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MEDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","market":"US","secType":"STK","nameCN":"HORIZON KINETICS MEDICAL ETF","latestPrice":34.9572,"timestamp":1789156800000,"preClose":35.0604,"halted":0,"volume":1892,"hourTrading":{"tag":"盘后","latestPrice":35,"preClose":34.9572,"latestTime":"16:10 EDT","volume":8,"amount":279.3488,"timestamp":1789157404699,"change":0.0428,"changeRate":0.001224,"amplitude":0},"delay":0,"changeRate":-0.002943491802717626,"floatShares":469946,"shares":469946,"eps":0,"marketStatus":"Market Closed","change":-0.1032,"latestTime":"09-11 16:00:00 EDT","open":35.1,"high":35.1,"low":34.9572,"amount":66279,"amplitude":0.004073,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":35.0604,"sharesOutstanding":569946,"nav":35.04,"aum":16466907.84,"dividendRate":0.011734,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35,"preClose":34.9572,"latestTime":"16:10 EDT","volume":8,"amount":279.3488,"timestamp":1789157404699,"change":0.0428,"changeRate":0.001224,"amplitude":0},"volumeRatio":0.7312359869705651},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","floatShares":469946,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7312359869705651,"shares":469946,"dividePrice":0.4102,"high":35.1,"amplitude":0.004073,"preClose":35.0604,"low":34.9572,"week52Low":28.8652,"pbRate":"--","week52High":37.9,"institutionHeld":0,"latestPrice":34.9572,"eps":0,"divideRate":0.011734,"volume":1892,"delay":0,"ttmEps":0,"open":35.1,"prevYearClose":33.2024,"prevWeekClose":36.6906,"prevMonthClose":36.417,"prevQuarterClose":36.7138,"fiveDayClose":37.0834,"twentyDayClose":35.9599,"sixtyDayClose":34.1895},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDX\",params:#limit:5,,,undefined,":[{"date":"2025-12-23","symbol":"MEDX","amount":0.4088,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2024-12-24","symbol":"MEDX","amount":0.502335,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"MEDX","amount":1.379798,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"HORIZON KINETICS MEDICAL ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":1.379798,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.502335,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-24","value":0.4088,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDX\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1121796426","title":"Brain-Computer Interface Startups Must Walk the Line Between Vast Potential and Near-Term Medical Reality, Says Formatia Founder","url":"https://stock-news.laohu8.com/highlight/detail?id=1121796426","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121796426?lang=en_us&edition=fundamental","pubTime":"2026-09-05 14:10","pubTimestamp":1788588618,"startTime":"0","endTime":"0","summary":"At the 2026 Yabuli Forum Summer Annual Meeting, held September 4-6 in Chengdu, Sichuan, under the theme \"Enterprise Innovation and Cycle Crossing,\" Formatia Founder and CEO Peng Lei offered a...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09996","GDOC","IEIH","AGNG","BK1583","MNTL","PTH","MDEV","BK1574","HART","IBRN","RSPH","LNGR","BK1100","159883","MEDX","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665779357","title":"Top Johnson & Johnson Executive Makes Major Stock Move","url":"https://stock-news.laohu8.com/highlight/detail?id=2665779357","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665779357?lang=en_us&edition=fundamental","pubTime":"2026-09-05 10:09","pubTimestamp":1788574195,"startTime":"0","endTime":"0","summary":"New insider activity at Johnson & Johnson ( ($JNJ) ) has taken place on September 4, 2026. Timothy Schmid, EVP and Worldwide Chair of MedTech at Jo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-johnson-johnson-executive-makes-major-stock-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-johnson-johnson-executive-makes-major-stock-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VHT","LU1196500208.SGD","IXJ","IE00BDGV0183.EUR","LU0912757837.SGD","BK4592","MEDX","TRUH","GDOC","FHLC","LU0124676726.USD","LU0943347566.SGD","LU1228905540.USD","IE000F7OJYX1.SGD","LU0070217475.USD","LU2417539215.USD","LU1043141123.HKD","LU0882574055.USD","PJP","RXL","IE00BJJMRZ35.SGD","SG9999001440.SGD","FTXH","LU0683600562.USD","IYH","LU1066053197.SGD","IHE","LU1291159041.SGD","LU1551013425.SGD","LU1244550494.USD","LU0203345920.USD","LU1043141396.HKD","LU0795875086.SGD","LU0792757196.USD","LU2592432038.USD","IE00B19Z3581.USD","LU2505996681.GBP","JNJ","LU2487616109.SGD","JDOC","XLV","SG9999002224.SGD","LU2129689514.USD","LU0640476718.USD","BMED","LU0203347892.USD","LU1506573853.SGD","IE00BKVL7J92.USD","BK4007","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665524173","title":"Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2665524173","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665524173?lang=en_us&edition=fundamental","pubTime":"2026-09-05 07:55","pubTimestamp":1788566100,"startTime":"0","endTime":"0","summary":"A highly anticipated cholesterol drug from Novartis failed to reduce the risk of severe cardiovascular outcomes in a Phase 3 study, dealing a blow to the company and others exploring a new approach to","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","BK4585","LU0320765489.SGD","LU0211331839.USD","IE00B4R5TH58.HKD","BK4588","BK4532","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0070302665.USD","BK4578","MEDX","BK4007","IE00B2B36J28.USD","IE0002141913.USD","PPH","NVS","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665352693","title":"Stocks to Watch: Ionis Pharmaceuticals, Novartis, Corvex","url":"https://stock-news.laohu8.com/highlight/detail?id=2665352693","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665352693?lang=en_us&edition=fundamental","pubTime":"2026-09-05 06:58","pubTimestamp":1788562680,"startTime":"0","endTime":"0","summary":"A heart disease drug made by Ionis Pharmaceuticals and Novartis didn't meet its primary endpoint in a Phase 3 trial. Ionis shares slid 9.5% to $52.60 in after-hours trading on Friday, while Novartis shares were off 4.4% at $153.04.Corvex said it had a loss of $26.3 million in the first half of the year. The stock fell 7.5% to $13.63 after the bell.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4578","IE0009355771.USD","IE00B4R5TH58.HKD","LU0211331839.USD","BK4585","IE0002141913.USD","BK4139","MEDX","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BK4007","LU0208291251.USD","NVS","PPH","IE00B2B36J28.USD","LU0320765489.SGD","IE00BFTCPJ56.SGD","BK4588","LU0070302665.USD","MOVE","BK4532","IONS","BK4170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665354352","title":"Novartis Pelacarsen Fails Phase III Cardiovascular Outcomes Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665354352","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665354352?lang=en_us&edition=fundamental","pubTime":"2026-09-05 06:36","pubTimestamp":1788561414,"startTime":"0","endTime":"0","summary":"Novartis AG (NVS) said Friday its Phase III Lp(a)HORIZON trial of pelacarsen did not meet its primary endpoint of reducing the risk of cardiovascular events compared with placebo.The primary endpoint ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LU0070302665.USD","PPH","IE00BJT1NW94.SGD","BK4585","IE0002141913.USD","IE0009355771.USD","BK4532","IE00BJJMRZ35.SGD","LU0208291251.USD","IE00B4R5TH58.HKD","LU0320765489.SGD","MEDX","BK4007","CSII","IE00B2B36J28.USD","LU0211331839.USD","BK4578","IE00BFTCPJ56.SGD","NVS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665535175","title":"Novartis announces Phase 3 pelacarsen study did not meet primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2665535175","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665535175?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:55","pubTimestamp":1788555312,"startTime":"0","endTime":"0","summary":"Ionis Pharmaceuticals (IONS) partner Novartis (NVS) announced that the pelacarsen Phase 3 Lp(a)HORIZON study, a pioneering cardiovascular outcomes ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-announces-phase-3-pelacarsen-study-did-not-meet-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-announces-phase-3-pelacarsen-study-did-not-meet-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","BK4578","BK4588","NVS","BK4007","LU0320765489.SGD","IE00B2B36J28.USD","BK4139","IE0002141913.USD","IONS","BK4585","LU0208291251.USD","LU0070302665.USD","MEDX","PPH","LU0211331839.USD","BK4532","IE00B4R5TH58.HKD","IE0009355771.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665351234","title":"Estee Lauder Cos. Cl a Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2665351234","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665351234?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:55","pubTimestamp":1788555300,"startTime":"0","endTime":"0","summary":"DJ Estee Lauder Cos. Cl A Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Estee Lauder Cos. Cl A  advanced 2.97% to $103.86 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.38% to 7,718.60 and Dow Jones Industrial Average  falling 0.51% to 53,414.25.Estee Lauder Cos. Cl A closed 14.61% below its 52-week high of $121.64, which the company achieved on February 3rd.The stock outperformed some of its competitors Friday, as Johnson & Johnson  fell 1.15% to $275.23, Procter & Gamble Co.  fell 0.33% to $146.44, and Coty Inc. Cl A  remained unchanged.Trading volume  eclipsed its 50-day average volume of 3.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 4, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ","LU0795875169.SGD","LU1244550494.USD","SGXZ80539844.SGD","LU0058720904.USD","TRUO","LU1244550221.USD","PG","LU0098860793.USD","MEDX","IE00BDGV0183.EUR","GDOC","LU0690374615.EUR","LU0122379950.USD","XLV","BK4018","LU0912757837.SGD","LU1585245621.USD","VHT","LU1629891620.HKD","IE00B1XK9C88.USD","BMED","JDOC","LU1732799900.SGD","GLAM","XLP","LU0795875086.SGD","LU0942090050.USD","LU2242652126.USD","TRUH","IE00BJJMRZ35.SGD","FTXH","IYH","LU0545562505.USD","RXL","COTY","LU0640476718.USD","PJP","LU1988902786.USD","LU2471134523.USD","UGE","FSTA","LU1221951046.USD","FHLC","BK4534","LU2896262040.SGD","IE000BZT7R73.USD","IHE","IXJ","EL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665235141","title":"Novartis Says Pelacarsen Heart Disease Drug Missed Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2665235141","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665235141?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:50","pubTimestamp":1788555000,"startTime":"0","endTime":"0","summary":"Novartis said a heart disease drug did not meet its primary endpoint in a Phase 3 study.The company on Friday said that the drug, pelacarsen, did not reduce the risk of cardiovascular events--including deaths, heart attacks, and strokes--compared to a placebo.The drug did succeed in lowering lipoprotein levels, Novartis said.\"These are not the results we hoped for, but they provide important evidence that advances scientific understanding of the relationship between Lp lowering and cardiovascular outcomes and may help inform future approaches to cardiovascular risk management,\" Chief Medical Officer Shreeram Aradhye said.Pelacarsen was initially discovered and developed by Ionis Pharmaceuticals, before Novartis exercised an option to license development and commercialization rights for the drug in 2019.Shares of Novartis declined 4.4% to $153.00 in after-hours trading on Friday. Ionis shares were flat.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE0002141913.USD","IONS","BK4532","IE00BJJMRZ35.SGD","NVS","BK4588","IE00B2B36J28.USD","IE00B4R5TH58.HKD","PPH","BK4578","MEDX","IE00BFTCPJ56.SGD","LU0208291251.USD","LU0320765489.SGD","IE00BJT1NW94.SGD","LU0070302665.USD","BK4139","BK4007","IE0009355771.USD","LU0211331839.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665513783","title":"AbbVie Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2665513783","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665513783?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:31","pubTimestamp":1788553860,"startTime":"0","endTime":"0","summary":"DJ AbbVie Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AbbVie Inc.  shed 1.44% to $256.46 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.38% to 7,718.60 and Dow Jones Industrial Average  falling 0.51% to 53,414.25.This was the stock's second consecutive day of losses.AbbVie Inc. closed 4.12% below its 52-week high of $267.47, which the company achieved on July 29th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  fell 1.15% to $275.23, Pfizer Inc.  fell 1.25% to $28.45, and Amgen Inc.  fell 1.55% to $437.23.Data source: Dow Jones Market Data, FactSet. Data compiled September 4, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0310800379.SGD","LU0310799852.SGD","LU1267930490.SGD","IE00B2B36J28.USD","LU0417517546.SGD","IYH","LU0069063385.USD","LU2089984988.USD","LU2125909247.SGD","IE00BVYPNV92.GBP","LU0122379950.USD","BK4559","LU0868494617.USD","BK4550","LU1585245621.USD","LU0820561909.HKD","LU1236620750.USD","LU1989772840.SGD","LU0234570918.USD","IXJ","LU0942090050.USD","LU1732799900.SGD","IE00BN8TJ469.HKD","LU0689626769.HKD","LU2237443895.HKD","IE000SO60NU8.SGD","LU0158827948.USD","LU1496350171.SGD","LU1037948541.HKD","LU0058720904.USD","IE0002270589.USD","IE0002141913.USD","BK4139","LU0198837287.USD","LU0943347566.SGD","LU0170899867.USD","LU1162221912.USD","LU1934455863.HKD","LU0545039389.USD","LU1732800096.USD","IE0009355771.USD","LU1551013342.USD","LU1839511570.USD","TRUH","LU1934455194.USD","LU0320765646.SGD","BK4585","LU1989771016.USD","LU1929549753.HKD","IE00BVYPNW00.USD","MEDX","LU0912757837.SGD","IE00BJT1NW94.SGD","LU1934455277.USD","IE00B19Z3581.USD","IE00BBT3K403.USD","JDOC","LU0708994859.HKD","LU0432979614.USD","LU2237443382.USD","IE00B3PB1722.GBP","LU1057294990.SGD","LU1236620834.HKD","LU1983299246.USD","LU1093756168.USD","LU0256863902.USD","LU2237443622.USD","AGNG","SG9999003800.SGD","LU0553294199.USD","IE00BGHQF631.EUR","LU0203345920.USD","IE000MB6IJN5.SGD","LU0203347892.USD","LU1074936037.SGD","VHT","IE000F7OJYX1.SGD","IE00B42XCP33.USD","LU2089284900.SGD","LU0289961442.SGD","LU0965509101.SGD","SG9999015986.USD","IE00B19Z3B42.SGD","LU0234572021.USD","LU0795875169.SGD","LU2357627491.SGD","PJP","LU0057025933.USD","LU1244550494.USD","LU2347655073.USD","SG9999015978.USD","LU2129689431.USD","BK4533","LU0098860793.USD","LU1670628061.USD","LU2087621335.USD","LU1923622614.USD","LU2112291526.USD","LU2347655156.SGD","LU0289739699.SGD","IE00BSNM7G36.USD","LU1551013425.SGD","LU2129689605.HKD","LU0289739343.SGD","LU0124676726.USD","LU2089283258.USD","LU0689472784.USD","RXL","PPH","LU1023059063.AUD","SG9999001440.SGD","BK4588","LU0211328371.USD","IE00BLSP4452.SGD","LU0949170772.SGD","LU0256863811.USD","IE000BZT7R73.USD","LU0128525929.USD","LU1989772923.USD","IE00BLSP4239.USD","LU2125909593.SGD","IE00BDGV0183.EUR","LU2237443549.SGD","LU2433249047.HKD","BK4566","BK4534","LU1496350502.SGD","LU1244550577.SGD","LU0114720955.EUR","SG9999015945.SGD","LU0661504455.SGD","LU0511384066.AUD","IE0004445239.USD","LU1061106388.HKD","LU0029864427.USD","LU2237443978.SGD","LU0965509283.SGD","LU0859254822.USD","LU1670627923.USD","LU0211327993.USD","IE0000B7K699.USD","LU2468319806.SGD","LU0965509010.AUD","LU1093756325.SGD","LU1430594728.SGD","LU2237443465.HKD","IE000WAW04H5.SGD","IE00BFTCPJ56.SGD","BK4581","ABBV","GLAM","LU0738911758.USD","LU1267930573.SGD","LU0795875086.SGD","LU2023251221.USD","LU0868494708.USD","LU1291159041.SGD","LU0965508806.USD","LU2129689514.USD","LU1003077747.HKD","LU0882574055.USD","LU0820561818.USD","IE00BJJMRZ35.SGD","XLV","LU0823416689.USD","LU0395794307.EUR","LU2133065610.SGD","LU0985320562.USD","FTXH","LU0456855351.SGD","LU1718418525.SGD","LU0472753341.HKD","IE00B4R5TH58.HKD","LU1037948897.HKD","SG9999015952.SGD","LU1244550221.USD","SG9999011175.SGD","LU0726765562.USD","LU0861579265.USD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665351836","title":"Healthcare Stocks Pick up Steam as Investors Play Offense and Defense","url":"https://stock-news.laohu8.com/highlight/detail?id=2665351836","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665351836?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:22","pubTimestamp":1788553320,"startTime":"0","endTime":"0","summary":"Want a prescription for investing success?","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ81514606.USD","IE00BN29S564.USD","LU0238689110.USD","LU0323591593.USD","IE00BKPKM429.USD","LU0097036916.USD","LU2023250330.USD","SG9999014914.USD","IE00BJJMRX11.SGD","LU0882574139.USD","LU0096364046.USD","LU1868837136.USD","LU2168564065.EUR","LU2023251221.USD","IE00BWXC8680.SGD","LU2746668974.SGD","IBB","TRUH","LU0256863902.USD","XLV","SG9999018865.SGD","SG9999018857.SGD","LU2471134952.CNY","LU0943347566.SGD","LU1323610961.USD","LU0109394709.USD","LU0672654240.SGD","SG9999014880.SGD","BK4007","LU0133085943.USD","IE0004445239.USD","LU0289739699.SGD","IE00B4R5TH58.HKD","LU0823434583.USD","LU2063271972.USD","SG9999015986.USD","LU2357305700.SGD","WDNA","LU2491049909.HKD","MRNY","LU0109391861.USD","LU0787776722.HKD","LU1145028129.USD","BK4588","LU1988902786.USD","LU2236285917.USD","ILDR","LU0122379950.USD","LU2602419157.SGD","HRTS","LU2237438978.USD","LU2361044865.SGD","LU1712237335.SGD","LU0354030438.USD","ELIS","LU2462591350.SGD","LU0114720955.EUR","FTXH","CANC","IE00BJLML261.HKD","LU1868836757.USD","LU0820562030.AUD","IE00B1XK9C88.USD","LU0174119429.USD","LU0708995401.HKD","LU2237443895.HKD","LU2168564495.EUR","BK4516","LU1280957306.USD","BK4581","LU2491050071.SGD","AGNG","IE00BJJMRY28.SGD","LU1629891620.HKD","LU2746668461.USD","BK4532","LU0471298777.SGD","LU0882574055.USD","BK4533","IE0002141913.USD","IE00BFTCPJ56.SGD","BK4501","LU1069344957.HKD","LU2089984988.USD","IE00B1BXHZ80.USD","LLII","LU1720051108.HKD","SG9999001176.SGD","LU0203202063.USD","LU0466842654.USD","LU0820561909.HKD","LU0158827781.USD","LLY","LU2361045086.USD","LU0964807845.USD","BK4534","LLYZ","LU1720051017.SGD","LU0345770993.USD","LU0225283273.USD","MHIP","THNR","LU2106854487.HKD","LU0353189680.USD","LU1035775433.USD","LU1093756325.SGD","LU2417539215.USD","LU2756315318.SGD","LU2471134879.HKD","SG9999014898.SGD","LU0432979614.USD","LU2471134523.USD","LU2237443549.SGD","LU0345770308.USD","LU2168564222.USD","BK4599","LU2324357040.USD","LU2361044949.HKD","LU2213496289.HKD","OZEM","LU0266013472.USD","LU2111349929.HKD","LU0456855351.SGD","LU2264538146.SGD","BK4585","LU2089283258.USD","LU2552382215.SGD","RXL","IHE","LU2237443465.HKD","LU0210536198.USD","LU0320765059.SGD","LU0385154629.USD","IE0005OL40V9.USD","LU0106261372.USD","LU2896262040.SGD","BK4548","MRNX","SG9999015945.SGD","LU0158827948.USD","LU2462157665.USD","ELIL","PPH","LABU","LU2552382132.HKD","LU2552382058.USD","SGXZ51526630.SGD","SGXZ99366536.SGD","LU2112291526.USD","LU0417517546.SGD","IE0004445015.USD","LU0058720904.USD","LU1232071149.USD","LU0203201768.USD","LU0320765992.SGD","LU1023059063.AUD","IE00B775H168.HKD","LU2456880835.USD","LU2750360641.GBP","LU2265009873.SGD","SG9999014906.USD","LU1064131342.USD","LU1291159041.SGD","LU0061475181.USD","IE00BJJMRZ35.SGD","PJP","LU1868837300.USD","LU1061106388.HKD","GDOC","LU0006306889.USD","LU0316494557.USD","LU0823416689.USD","LU1623119135.USD","LU1804176565.USD","LU2087625088.SGD","BK4139","BK4551","LU1868836914.USD","SG9999017495.SGD","LU1366192091.USD","LU1551013425.SGD","LU2168563687.JPY","IE00B4JS1V06.HKD","LU2471134796.USD","SG9999015952.SGD","LU0689472784.USD","LU1127390331.HKD","XBI","LU2237443382.USD","LU1917777945.USD","LU2237443622.USD","LU2023250504.SGD","LU1093756168.USD","SG9999013999.USD","IE00BJT1NW94.SGD","BK4568","IE00B2B36J28.USD","IE00BFSS7M15.SGD","LU0889565916.HKD","IE0009355771.USD","LU2271345857.HKD","TMED","LU0820561818.USD","GNOM","LU0354030511.USD","SG9999015978.USD","LU2461242641.AUD","LU2360106947.USD","LU2237443978.SGD","LU1868836591.USD","LU0234572021.USD","MEDI","LU2089284900.SGD","JDOC","LU0823434740.USD","FHLC","LU1989771016.USD","LU0471298694.HKD","MEDX","SGXZ31699556.SGD","LU1551013342.USD","LU1974910355.USD","LU2108987350.USD","LU0198837287.USD","LU2491050154.USD","IE00BK4W5M84.HKD","LLYX","LU1057294990.SGD","LU2756315664.SGD","LU1983299246.USD","IHF","IE00BKDWB100.SGD","LU1548497426.USD","LU1814569148.SGD","LU0079474960.USD","LU0256863811.USD","LU1267930730.SGD","MRNA","LU1691799644.USD","LGHT","LU0353189763.USD","LU2750360997.AUD","LU0094547139.USD","LU2211815571.USD","IE00BFSS8Q28.SGD","IE00BK4W5L77.USD","LU0786609619.USD","LU0640476718.USD","LU2468319806.SGD","SGXZ57979304.SGD","GB00BDT5M118.USD","LU0683600562.USD","LU2168564149.EUR","LU2028103732.USD","IE00B7KXQ091.USD","LU1979441026.SGD","SG9999001176.USD","IDNA","IE0001KFT4U8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665735956","title":"Mizuho survey shows no consensus into Alkermes ADHD data","url":"https://stock-news.laohu8.com/highlight/detail?id=2665735956","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665735956?lang=en_us&edition=fundamental","pubTime":"2026-09-05 03:35","pubTimestamp":1788550508,"startTime":"0","endTime":"0","summary":"Mizuho conducted a survey of 13 investors ahead of Alkermes (ALKS)’ Phase 1b trial of ALKS-7290 in adult attention-deficit/hyperactivity disorder, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mizuho-survey-shows-no-consensus-into-alkermes-adhd-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mizuho-survey-shows-no-consensus-into-alkermes-adhd-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","ALKS","IBRN","PSCH","MEDX","BK4139","FBT","ADHD","ABVC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665135376","title":"Lilly Targets Type 1 Diabetes With New Tirzepatide Study: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2665135376","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665135376?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:31","pubTimestamp":1788539464,"startTime":"0","endTime":"0","summary":"Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Eli Lilly and Company (LLY) is launching a new Phase 1 study on t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lilly-targets-type-1-diabetes-with-new-tirzepatide-study-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lilly-targets-type-1-diabetes-with-new-tirzepatide-study-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2361045086.USD","LU0158827781.USD","SG9999013999.USD","SG9999014914.USD","LU0889565916.HKD","LU1035775433.USD","IE00BJT1NW94.SGD","IE0005OL40V9.USD","LU0640476718.USD","IE00BKDWB100.SGD","IE00BN29S564.USD","LU2324357040.USD","BK4581","LU0320765992.SGD","LU1623119135.USD","LU1127390331.HKD","LU2746668974.SGD","FTXH","LU0114720955.EUR","IE00BFTCPJ56.SGD","LU0672654240.SGD","LU1868836914.USD","SG9999014898.SGD","LU1720051108.HKD","BK4534","OZEM","IE00B4R5TH58.HKD","GB00BDT5M118.USD","LU2357305700.SGD","IE00BJJMRY28.SGD","IYH","LU0079474960.USD","LU2237443382.USD","LU0943347566.SGD","LU2089283258.USD","LU1974910355.USD","LU0323591593.USD","TRUH","LU0225283273.USD","LU2552382132.HKD","SG9999015952.SGD","SGXZ99366536.SGD","LU0787776722.HKD","LU0823434583.USD","LU1712237335.SGD","LU2417539215.USD","TMED","LU2237443978.SGD","LU1983299246.USD","LU2756315664.SGD","IE00B1BXHZ80.USD","ELIS","IE0001KFT4U8.USD","LU0133085943.USD","SGXZ31699556.SGD","VHT","LU2237443622.USD","BK4599","IE00B7KXQ091.USD","LU2087625088.SGD","LU2471134796.USD","LU1061106388.HKD","LU0345770993.USD","LU2491050071.SGD","LU1280957306.USD","LU0096364046.USD","LU2361044865.SGD","LU2552382058.USD","LU1232071149.USD","SG9999015978.USD","LU0174119429.USD","IE00B775H168.HKD","SGXZ51526630.SGD","IE0009355771.USD","LLYX","LU1069344957.HKD","LU1804176565.USD","LU0256863811.USD","LU0354030438.USD","LU0471298777.SGD","LU1868837136.USD","PPH","LU1814569148.SGD","LU0708995401.HKD","BK4533","LU1366192091.USD","LU1868837300.USD","ELIL","LU2211815571.USD","IE00BJJMRZ35.SGD","SG9999001176.USD","LU2063271972.USD","LU2264538146.SGD","IE00BK4W5L77.USD","LU0882574139.USD","LU0882574055.USD","LU2023251221.USD","IE00BJLML261.HKD","LU0820562030.AUD","LU2108987350.USD","LU0823434740.USD","IE00BFSS7M15.SGD","LU0058720904.USD","SG9999018865.SGD","LU2168564065.EUR","LU2213496289.HKD","LU2471134879.HKD","MEDX","LU0109394709.USD","MEDI","LU0320765059.SGD","LU2089284900.SGD","LU2265009873.SGD","LU2468319806.SGD","IE00BKPKM429.USD","LU2168564222.USD","SG9999015986.USD","BK4516","LU1868836591.USD","SG9999014880.SGD","LU2461242641.AUD","LU0964807845.USD","LU1629891620.HKD","SGXZ57979304.SGD","LU0823416689.USD","IE0002141913.USD","IE0004445239.USD","BK4588","LU0094547139.USD","BK4007","LU0289739699.SGD","LU2756315318.SGD","LU2750360641.GBP","LLII","WDNA","LU2023250504.SGD","SG9999015945.SGD","LU1267930730.SGD","LU0466842654.USD","LU0353189763.USD","LU0471298694.HKD","LU0820561909.HKD","LU2111349929.HKD","LU2462591350.SGD","THNR","IE00BK4W5M84.HKD","LU2750360997.AUD","IE00B1XK9C88.USD","LU0198837287.USD","IE00BWXC8680.SGD","LU1291159041.SGD","LLYZ","SG9999001176.SGD","LU0210536198.USD","LU0316494557.USD","LU2491050154.USD","LU2106854487.HKD","LU1023059063.AUD","LU1917777945.USD","LU2271345857.HKD","LU0097036916.USD","LU0203201768.USD","LU0061475181.USD","LU2471134952.CNY","LU0353189680.USD","ILDR","PJP","LU2471134523.USD","LU2896262040.SGD","IE00BJJMRX11.SGD","LU2089984988.USD","RXL","LU0385154629.USD","LU0256863902.USD","LU0122379950.USD","BK4585","LU2168564149.EUR","LU2236285917.USD","GDOC","SG9999017495.SGD","IE00BFSS8Q28.SGD","LU2462157665.USD","LU2361044949.HKD","LU0689472784.USD","LU0266013472.USD","LU2456880835.USD","SG9999018857.SGD","LU2360106947.USD","LU0432979614.USD","LU2237443895.HKD","LU2023250330.USD","LU1720051017.SGD","LU1979441026.SGD","CURE","LU1323610961.USD","LU1868836757.USD","LU2237438978.USD","SGXZ81514606.USD","AGNG","CANC","FHLC","IXJ","LU0354030511.USD","IE00B4JS1V06.HKD","LU1064131342.USD","LU0345770308.USD","LU1989771016.USD","LU2168563687.JPY","LU0203202063.USD","LLY","LU1691799644.USD","LU0820561818.USD","LU2552382215.SGD","LU0006306889.USD","LU0786609619.USD","LU0417517546.SGD","LU1551013425.SGD","MHIP","LU0158827948.USD","IE00B2B36J28.USD","LU1093756168.USD","LU2746668461.USD","IHE","HRTS","LU2237443549.SGD","IE0004445015.USD","LU0238689110.USD","LU1548497426.USD","LU1145028129.USD","LU0683600562.USD","LU2028103732.USD","LU0234572021.USD","LU2112291526.USD","LU1988902786.USD","LU0109391861.USD","JDOC","LU2491049909.HKD","XLV","LU1057294990.SGD","LU2237443465.HKD","LU0106261372.USD","SG9999014906.USD","LU1093756325.SGD","LU2602419157.SGD","LU0456855351.SGD","LU1551013342.USD","LU2168564495.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665635396","title":"Novartis AG Falls Friday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2665635396","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665635396?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:15","pubTimestamp":1788538500,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novartis AG  dropped 1.3% to CHF129.58 Friday on what proved to be an overall mediocre trading session for the stock market, with the Swiss Market Index SMI Index  holding steady at 14,395.94.Novartis AG closed CHF3.10 short of its 52-week high of CHF132.68, which the company achieved on September 3, 2026.Trading volume was 2,616,060, compared to the 50-day average trading volume of 2,312,024.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","BK4585","LU0320765489.SGD","LU0211331839.USD","IE00B4R5TH58.HKD","BK4588","BK4532","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0070302665.USD","BK4578","MEDX","BK4007","IE00B2B36J28.USD","IE0002141913.USD","PPH","NVS","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664375653","title":"Drugmakers Halt Autoimmune Trials After Deaths, Life-Threatening Side Effects","url":"https://stock-news.laohu8.com/highlight/detail?id=2664375653","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664375653?lang=en_us&edition=fundamental","pubTime":"2026-09-04 21:42","pubTimestamp":1788529320,"startTime":"0","endTime":"0","summary":"Bristol Myers Squibb told regulators, researchers and patient-advocacy groups in early June that it had paused closely watched drug research because of life-threatening side effects. It took three mon","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","IHE","LU1670711123.USD","IE00BJJMRZ35.SGD","PPH","FTXH","LU0114720955.EUR","LU0882574055.USD","IE00BJT1NW94.SGD","LU0225771236.USD","LU1236620834.HKD","LU1670710588.SGD","IE0002141913.USD","LU1868836757.USD","LU0061475181.USD","BMY","LU1430594728.SGD","LU1670710661.SGD","IE00B4R5TH58.HKD","LU1093756325.SGD","LU2133065610.SGD","LU1670711040.USD","LU1571399168.USD","IE00BSNM7G36.USD","LU0868494617.USD","BK4532","IE00BFXG1179.USD","LU0306806265.USD","LU0306807586.USD","LU0321505439.SGD","LU2242646821.SGD","LU0096364046.USD","LU1989771016.USD","LU1883839398.USD","LU2360032135.SGD","LU1983299246.USD","LU0267386448.USD","LU1291159041.SGD","IE00B2B36J28.USD","LU0321505868.SGD","NVS","LU2596442595.SGD","BK4578","LU0320765489.SGD","IE0009355771.USD","LU0070302665.USD","LU0985481810.HKD","BK4534","LU1585245621.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664162337","title":"Analysts Are Bullish on Top Healthcare Stocks: Annovis Bio (ANVS), AbbVie (ABBV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664162337","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664162337?lang=en_us&edition=fundamental","pubTime":"2026-09-04 21:40","pubTimestamp":1788529214,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Annovis Bio (ANVS), AbbVie (ABBV) and Glaukos (GKOS)...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-annovis-bio-anvs-abbvie-abbv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-annovis-bio-anvs-abbvie-abbv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0689626769.HKD","SG9999015945.SGD","LU0029864427.USD","HCSG","IE00BJJMRZ35.SGD","LU0122379950.USD","LU1732799900.SGD","LU0211328371.USD","LU1057294990.SGD","ANVS","LU1718418525.SGD","GKOS","FTXH","IXJ","VHT","LABU","LU0965509010.AUD","IE00BLSP4452.SGD","PJP","RXL","AGNG","IE00BSNM7G36.USD","TRUH","FHLC","LU2347655156.SGD","LU0128526141.USD","LU1074936037.SGD","LU1934455194.USD","BK4533","LU2237443622.USD","BK4585","LU0472753341.HKD","IE00BBT3K403.USD","MEDX","LU0128525929.USD","PPH","LU0211327993.USD","JDOC","SG9999015986.USD","XLV","LU1430594728.SGD","LU2125909593.SGD","GLAM","LU0708994859.HKD","IYH","XBI","LU1923622614.USD","ABBV","IE0002270589.USD","IE00BN8TJ469.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664204332","title":"Wuhan Dazhong Dental Proposes Wang Hong as Executive Director to Replace Guo Jiaping","url":"https://stock-news.laohu8.com/highlight/detail?id=2664204332","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664204332?lang=en_us&edition=fundamental","pubTime":"2026-09-04 21:30","pubTimestamp":1788528637,"startTime":"0","endTime":"0","summary":"Wuhan Dazhong Dental proposes Wang Hong as executive director to replace Guo JiapingWuhan Dazhong Dental Medical proposed appointing vice general manager Wang Hong as an executive director, pending sh","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDLbWh1cr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0820561909.HKD","SG9999001440.SGD","IE000MB6IJN5.SGD","LU2750360997.AUD","02651","LU0912757837.SGD","LU1066051498.USD","BMED","LU0792757196.USD","IE00BLSP4239.USD","LU2430703251.USD","FHLC","IXJ","LU1894683264.USD","BK1515","FTXH","LU0345769128.USD","LU2430703178.SGD","LU0053666078.USD","IE00BDGV0183.EUR","LU0820562030.AUD","LU0058720904.USD","IYH","PJP","LU0943347566.SGD","01177","IHE","LU2471134523.USD","LU1732799900.SGD","MEDX","TRUH","LU0234572021.USD","LU1244550577.SGD","IE00BZ08YR35.GBP","RXL","JDOC","IE00B3T34201.USD","LU1894683348.USD","LU1929549753.HKD","LU2592432038.USD","LU0964807845.USD","LU1057294990.SGD","LU2756315664.SGD","XLV","VHT","IE0002141913.USD","GDOC","LU1061106388.HKD","JNJ","LU1551013342.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664433239","title":"J&J EVP, Worldwide Chair MedTech Timothy Schmid Disposes of 33,597 Common Shares Worth $9.23 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664433239","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664433239?lang=en_us&edition=fundamental","pubTime":"2026-09-04 21:08","pubTimestamp":1788527330,"startTime":"0","endTime":"0","summary":"J&J EVP, Worldwide Chair MedTech Timothy Schmid disposes of 33,597 common shares worth $9.23 millionJohnson & Johnson EVP, WW Chair, MedTech Timothy Schmid sold 33,597 common shares on Sep. 2, 2026 at","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL2c7TF8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"J&J EVP, Worldwide Chair MedTech Timothy Schmid Disposes of 33,597 Common Shares Worth $9.23 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0820562030.AUD","PJP","BK4550","LU1280957306.USD","IE00BN8TJ469.HKD","IE00B19Z3B42.SGD","LU2417539215.USD","LU1228905540.USD","LU2430703251.USD","SG9999001176.USD","GDOC","VHT","IE00B42XCP33.USD","IE00BLSP4452.SGD","LU1228905037.USD","FHLC","LU0795875086.SGD","LU2471134879.HKD","RXL","XLV","BMED","TRUH","LU1551013425.SGD","LU0964807845.USD","MEDX","LU1585245621.USD","IE000MB6IJN5.SGD","JDOC","LU1929549753.HKD","LU2505996509.AUD","LU0820561909.HKD","IE00BLSP4239.USD","BK4568","SG9999002224.SGD","LU0072461881.USD","LU1244550494.USD","IHE","LU2129689514.USD","IE00B2B36J28.USD","LU0820561818.USD","FTXH","IE00BFTCPJ56.SGD","IXJ","SG9999001440.SGD","LU0640476718.USD","LU1261432733.SGD","LU2471134796.USD","IYH","LU1718418525.SGD","JNJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103371342","title":"Traditional Chinese Medicine Firm Secures Regulatory Approval for New Depression Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1103371342","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103371342?lang=en_us&edition=fundamental","pubTime":"2026-09-04 20:54","pubTimestamp":1788526459,"startTime":"0","endTime":"0","summary":"TRAD CHI MED (00570) has announced that its subsidiary, Guizhou Tongjitang Pharmaceutical Co., Ltd., has received official market authorization from the National Medical Products Administration...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","IBBQ","00570","BK1606","BK1515","BK1574","BK1191","06978","159992","BK1161","LNGR","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664339449","title":"Scotiabank Remains a Buy on AbbVie (ABBV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664339449","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664339449?lang=en_us&edition=fundamental","pubTime":"2026-09-04 19:35","pubTimestamp":1788521731,"startTime":"0","endTime":"0","summary":"In a report released today, Louise Chen from Scotiabank maintained a Buy rating on AbbVie, with a price target of $280.00. Chen covers the Healthca...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/scotiabank-remains-a-buy-on-abbvie-abbv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/scotiabank-remains-a-buy-on-abbvie-abbv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0472753341.HKD","IYH","LU2347655073.USD","LU2433249047.HKD","LU2237443622.USD","AGNG","SG9999011175.SGD","LU2023251221.USD","LU0029864427.USD","MEDX","LU1670627923.USD","LU0949170772.SGD","LU1267930490.SGD","LU0553294199.USD","JDOC","FHLC","LU0820561818.USD","GLAM","LU0738911758.USD","LU1267930573.SGD","PJP","LU1057294990.SGD","VHT","ABBV","LU1236620834.HKD","LU1244550221.USD","FTXH","LU2237443978.SGD","LU0965508806.USD","LU1923622614.USD","PPH","LU0689472784.USD","SG9999015978.USD","IXJ","LU1983299246.USD","IE00BLSP4239.USD","LU1839511570.USD","LU0128525929.USD","TRUH","LU1162221912.USD","LU2129689605.HKD","XLV","LU0689626769.HKD","LU1291159041.SGD","LU0057025933.USD","RXL","IE000MB6IJN5.SGD","LU0114720955.EUR","LU0859254822.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168386192","title":"Guizhou-Based Firm Earns National Recognition for Veterans Support Efforts","url":"https://stock-news.laohu8.com/highlight/detail?id=1168386192","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168386192?lang=en_us&edition=fundamental","pubTime":"2026-09-04 19:31","pubTimestamp":1788521499,"startTime":"0","endTime":"0","summary":"A ceremony was held in Guiyang on September 3rd to award a national designation for veteran employment and entrepreneurship support. During the event, Guizhou Province's Songping Biotechnology Co.,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","BK4581","SYNB","LNGR","MEDX","BK4585","AGNG","IEIH","XBI","HBImain","IBBJ","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":15,"pageCount":9,"totalSize":299,"code":"91000000","status":"200"}]}}